Cargando…
In vivo efficacy and molecular docking of designed peptide that exhibits potent antipneumococcal activity and synergises in combination with penicillin
We have previously designed a series of antimicrobial peptides (AMPs) and in the current study, the in vivo therapeutic efficacy and toxicity were investigated. Among all the peptides, DM3 conferred protection to a substantial proportion of the lethally infected mice caused by a strain of penicillin...
Autores principales: | Le, Cheng-Foh, Yusof, Mohd Yasim Mohd, Hassan, Mahmood Ameen Abdulla, Lee, Vannajan Sanghiran, Isa, Diyana Mohd, Sekaran, Shamala Devi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496672/ https://www.ncbi.nlm.nih.gov/pubmed/26156658 http://dx.doi.org/10.1038/srep11886 |
Ejemplares similares
-
In vitro properties of designed antimicrobial peptides that exhibit potent antipneumococcal activity and produces synergism in combination with penicillin
por: Le, Cheng-Foh, et al.
Publicado: (2015) -
Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae
por: Jindal, Hassan Mahmood, et al.
Publicado: (2015) -
Capsular Serotype and Antibiotic Resistance of Streptococcus pneumoniae Isolates in Malaysia
por: Le, Cheng-Foh, et al.
Publicado: (2011) -
Novel Clones of Streptococcus pneumoniae Causing Invasive Disease in Malaysia
por: Jefferies, Johanna M., et al.
Publicado: (2014) -
Activity of Novel Synthetic Peptides against Candida albicans
por: Lum, Kah Yean, et al.
Publicado: (2015)